The North American Paget disease treatment market continues to hold a significant share of the global industry, supported by advanced healthcare infrastructure, strong diagnostic capabilities, and increased awareness of rare bone disorders. The United States remains the largest contributor to regional revenue due to its well-established healthcare system, widespread availability of...